Invivyd, Inc. (NASDAQ:IVVD) Short Interest Update

Invivyd, Inc. (NASDAQ:IVVD) saw a large increase in short interest in October. As of October 31st, there was short interest totalling 8,270,000 shares, an increase of 15.8% from the October 15th total of 7,140,000 shares. Based on an average trading volume of 463,300 shares, the short-interest ratio is currently 17.9 days. Currently, 11.4% of the company’s stock are sold short.

Analysts Set New Price Targets

Several research firms recently commented on IVVD. EF Hutton Acquisition Co. I upgraded shares of Invivyd to a “strong-buy” rating in a research note on Wednesday, October 30th. HC Wainwright restated a “buy” rating and set a $15.00 target price on shares of Invivyd in a research note on Tuesday, October 29th.

Hedge Funds Weigh In On Invivyd

A number of institutional investors have recently modified their holdings of the stock. Vanguard Group Inc. raised its holdings in Invivyd by 3.9% in the 1st quarter. Vanguard Group Inc. now owns 2,611,202 shares of the company’s stock worth $11,594,000 after purchasing an additional 97,496 shares during the period. State Street Corp boosted its position in shares of Invivyd by 3.7% during the 3rd quarter. State Street Corp now owns 1,018,640 shares of the company’s stock valued at $1,039,000 after acquiring an additional 35,904 shares during the last quarter. Marshall Wace LLP increased its stake in Invivyd by 4.2% during the second quarter. Marshall Wace LLP now owns 786,899 shares of the company’s stock worth $866,000 after acquiring an additional 31,992 shares during the last quarter. Acadian Asset Management LLC lifted its position in Invivyd by 232.0% in the second quarter. Acadian Asset Management LLC now owns 678,706 shares of the company’s stock valued at $745,000 after buying an additional 474,301 shares during the last quarter. Finally, Duquesne Family Office LLC acquired a new stake in shares of Invivyd in the second quarter valued at $629,000. Hedge funds and other institutional investors own 70.36% of the company’s stock.

Invivyd Stock Performance

Shares of IVVD stock opened at $0.76 on Monday. Invivyd has a fifty-two week low of $0.76 and a fifty-two week high of $5.20. The firm has a market capitalization of $90.19 million, a PE ratio of -0.39 and a beta of 0.65. The stock’s 50-day simple moving average is $0.99 and its 200-day simple moving average is $1.28.

Invivyd Company Profile

Invivyd, Inc, a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company developed INVYMAB, a platform that combines viral surveillance and predictive modeling with advanced antibody engineering.